Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.
暂无分享,去创建一个
Christopher P Cannon | E. Antman | E. Braunwald | C. Cannon | T. Henry | S. Murphy | C. McCabe | P. Shah | M. Bahit | C. Gibson | G. McKendall | Elliott M Antman | C Michael Gibson | Eugene Braunwald | Timothy D Henry | George R McKendall | Prediman K Shah | M. Gibson | M. Schweiger | Sabina Murphy | Carolyn H McCabe | Maria Cecilia Bahit | J Mark Haugland | Marc J Schweiger | J. Haugland | M. Haugland | C. Mccabe
[1] J. Gore,et al. Early and Pre-Discharge Aspirin Administration Among Patients with Acute Myocardial Infarction: Current Clinical Practice and Trends in the United States , 2000, Journal of Thrombosis and Thrombolysis.
[2] C Lenfant,et al. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. , 2001, Circulation.
[3] W. Rogers,et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.
[4] H A Feldman,et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. , 2000, JAMA.
[5] C M Gibson,et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. , 2000, JAMA.
[6] W. Rogers,et al. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability , 2000 .
[7] S. Osganian,et al. Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group. , 1999, American heart journal.
[8] J S Alpert,et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) , 1999, Circulation.
[9] C. Cannon,et al. Emergency department thrombolysis critical pathway reduces door‐to‐drug times in acute myocardial infarction , 1999, Clinical cardiology.
[10] Yuan Zhang,et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. , 1998, Circulation.
[11] A. Berman,et al. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. , 1997, American Journal of Cardiology.
[12] J. Ornato,et al. The Physician's Role in Minimizing Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction: Recommendations from the National Heart Attack Alert Program , 1997, Annals of Internal Medicine.
[13] E. Antman. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. , 1996, Circulation.
[14] R. Califf,et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. , 1995, Circulation.
[15] L. Bailey,et al. Pretransplant risk factors and causes of death or graft loss after heart transplantation during early infancy. Pediatric Heart Transplant Team, Loma Linda. , 1995, Circulation.
[16] R. M. Rubison,et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.
[17] C. Fry,et al. Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.
[18] Daniel B. Mark,et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. , 1994, Circulation.
[19] W. Rogers,et al. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. , 1994, The American journal of cardiology.
[20] L. Wilkins. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.
[21] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[22] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[23] W. Weaver,et al. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. , 1993, The New England journal of medicine.
[24] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[25] K. Mann,et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. , 1991, Annals of internal medicine.
[26] W. O’Neill,et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. , 1991, Annals of internal medicine.
[27] C. Grines,et al. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. , 1990, Journal of the American College of Cardiology.
[28] Y. Ohtsuki,et al. ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.
[29] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .